{
  "liso-cel": {
    "is_drug": true,
    "reason": "Search results indicate liso-cel (lisocabtagene maraleucel) is an FDA-approved CAR T-cell therapy used for the treatment of lymphoma.",
    "original_searched": "Liso-cel"
  },
  "axi-cel": {
    "is_drug": true,
    "reason": "Search results indicate that Axi-cel (axicabtagene ciloleucel) is an FDA-approved autologous anti-CD19 CAR T-cell therapy used for the treatment of relapsed or refractory B-cell lymphomas.",
    "original_searched": "Axi-cel"
  },
  "glofitamab": {
    "is_drug": true,
    "reason": "Search results indicate Glofitamab (Columvi) is an FDA-approved immunotherapy drug used to treat blood cancers such as diffuse large B-cell lymphoma.",
    "original_searched": "Glofitamab"
  },
  "rituximab": {
    "is_drug": true,
    "reason": "Search results indicate Rituximab is a monoclonal antibody used as a targeted cancer drug, FDA-approved and prescribed for conditions like non-Hodgkin's lymphoma and chronic lymphocytic leukemia.",
    "original_searched": "Rituximab"
  },
  "gemcitabine": {
    "is_drug": true,
    "reason": "Search results indicate gemcitabine is a drug used as standard therapy in cancer treatment and is administered in specific regimens for diseases such as pancreatic and lung cancer.",
    "original_searched": "Gemcitabine"
  },
  "oxaliplatin": {
    "is_drug": true,
    "reason": "Search results indicate that oxaliplatin is a cancer medication (platinum-based antineoplastic) used to treat colorectal cancer and is FDA approved.",
    "original_searched": "Oxaliplatin"
  },
  "doxorubicin": {
    "is_drug": true,
    "reason": "Search results indicate Doxorubicin is an FDA-approved chemotherapy medication used to treat cancer, also known by the brand name Adriamycin.",
    "original_searched": "Doxorubicin"
  },
  "cyclophosphamide": {
    "is_drug": true,
    "reason": "Search results indicate Cyclophosphamide is an FDA-approved drug used to treat cancers such as Hodgkin's lymphoma, non-Hodgkin's lymphoma, and multiple myeloma, and is described in drug information sources and treatment regimens.",
    "original_searched": "Cyclophosphamide"
  },
  "prednisone": {
    "is_drug": true,
    "reason": "Search results indicate Prednisone is an FDA-approved corticosteroid used as an anti-inflammatory and immunosuppressive agent for a variety of diseases.",
    "original_searched": "Prednisone"
  },
  "polatuzumab vedotin": {
    "is_drug": true,
    "reason": "Search results indicate that polatuzumab vedotin is an FDA-approved drug used in combination regimens for the treatment of diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma.",
    "original_searched": "Polatuzumab vedotin"
  },
  "vincristine": {
    "is_drug": true,
    "reason": "Search results indicate Vincristine is a chemotherapy medication used to treat various cancers, with brand names such as Oncovin, and is included in treatment regimens for gliomas.",
    "original_searched": "Vincristine"
  },
  "mosunetuzumab": {
    "is_drug": true,
    "reason": "Search results indicate Mosunetuzumab is FDA-approved for the treatment of relapsed or refractory follicular lymphoma in adults.",
    "original_searched": "Mosunetuzumab"
  },
  "zilovertamab vedotin": {
    "is_drug": true,
    "reason": "Search results describe zilovertamab vedotin as a novel antibody-drug conjugate (ADC) used in clinical trials for the treatment of lymphoid cancers, indicating it is a therapeutic agent.",
    "original_searched": "Zilovertamab vedotin"
  },
  "r-chp": {
    "is_drug": true,
    "reason": "Search results describe R-CHP as a standard chemotherapy regimen for diffuse large B-cell lymphoma, used as a comparator to Pola-R-CHP in clinical trials.",
    "original_searched": "R-CHP"
  },
  "r-chop": {
    "is_drug": true,
    "reason": "Search results indicate R-CHOP is a cancer treatment regimen combining five drugs, used as standard therapy for non-Hodgkin lymphoma and diffuse large B-cell lymphoma.",
    "original_searched": "R-CHOP"
  },
  "surovatamig": {
    "is_drug": true,
    "reason": "Search results indicate Surovatamig is a drug in Phase 3 development, described as a BiTE (bispecific T-cell engager) for relapsed/refractory B-ALL, with clinical studies and dosing regimens mentioned.",
    "original_searched": "Surovatamig"
  },
  "lenalidomide": {
    "is_drug": true,
    "reason": "Search results indicate Lenalidomide (Revlimid) is an FDA-approved immunomodulatory drug used in the treatment of multiple myeloma.",
    "original_searched": "Lenalidomide"
  },
  "zanubrutinib": {
    "is_drug": true,
    "reason": "Search results indicate Zanubrutinib (Brukinsa) is an FDA-approved BTK inhibitor used for the treatment of mantle cell lymphoma and other blood cancers.",
    "original_searched": "Zanubrutinib"
  },
  "etoposide": {
    "is_drug": true,
    "reason": "Search results indicate etoposide is a medication used in the treatment of various cancers and is described as an anti-neoplastic drug and chemotherapy agent.",
    "original_searched": "Etoposide"
  },
  "apixaban": {
    "is_drug": true,
    "reason": "Search results indicate Apixaban is an FDA-approved anticoagulant medication used to treat and prevent blood clots and stroke.",
    "original_searched": "Apixaban"
  },
  "warfarin": {
    "is_drug": true,
    "reason": "Search results consistently describe Warfarin as an oral anticoagulant drug used for the prevention and treatment of thromboembolic events.",
    "original_searched": "Warfarin"
  },
  "daratumumab": {
    "is_drug": true,
    "reason": "Search results indicate Daratumumab is an FDA-approved CD38-directed monoclonal antibody used for the treatment of multiple myeloma and light chain amyloidosis.",
    "original_searched": "Daratumumab"
  },
  "dexamethasone": {
    "is_drug": true,
    "reason": "Search results from MedlinePlus, Mayo Clinic, and DrugBank describe dexamethasone as a corticosteroid medication used therapeutically for various conditions.",
    "original_searched": "Dexamethasone"
  },
  "bortezomib": {
    "is_drug": true,
    "reason": "Search results indicate Bortezomib is an FDA-approved drug (marketed as Velcade) used for the treatment of multiple myeloma and mantle cell lymphoma.",
    "original_searched": "Bortezomib"
  },
  "belantamab mafodotin": {
    "is_drug": true,
    "reason": "Search results indicate Belantamab Mafodotin is an FDA-approved monoclonal antibody-drug conjugate used for the treatment of multiple myeloma.",
    "original_searched": "Belantamab Mafodotin"
  },
  "autologous stem cell": {
    "is_drug": true,
    "reason": "Search results indicate that autologous stem cells are used therapeutically in autologous stem cell transplantation for diseases like blood cancers, and the FDA considers many autologous cell therapies as drugs.",
    "original_searched": "Autologous Stem Cell"
  },
  "rivaroxaban": {
    "is_drug": true,
    "reason": "Search results indicate Rivaroxaban is an FDA-approved oral anticoagulant (factor Xa inhibitor) used to treat and prevent blood clots, including DVT, pulmonary embolism, and stroke prevention in atrial fibrillation.",
    "original_searched": "Rivaroxaban"
  },
  "r-minichop": {
    "is_drug": true,
    "reason": "Search results indicate R-miniCHOP is a chemotherapy regimen (including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) used as first-line treatment for diffuse large B-cell lymphoma in older or frail patients.",
    "original_searched": "R-minichop"
  },
  "venetoclax": {
    "is_drug": true,
    "reason": "Search results indicate Venetoclax is an FDA-approved oral BCL-2 inhibitor used for the treatment of chronic lymphocytic leukemia and other cancers.",
    "original_searched": "Venetoclax"
  },
  "tagraxofusp": {
    "is_drug": true,
    "reason": "Search results indicate Tagraxofusp (Elzonris) is an FDA-approved anti-cancer medication for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).",
    "original_searched": "Tagraxofusp"
  },
  "decitabine/cedazuridine": {
    "is_drug": true,
    "reason": "Search results indicate decitabine/cedazuridine is an FDA-approved combination drug used to treat myelodysplastic syndromes.",
    "original_searched": "decitabine/cedazuridine"
  },
  "sotalol": {
    "is_drug": true,
    "reason": "Search results indicate Sotalol is an FDA-approved antiarrhythmic drug used to treat ventricular tachycardia and atrial fibrillation.",
    "original_searched": "Sotalol"
  },
  "amiodarone": {
    "is_drug": true,
    "reason": "Search results indicate Amiodarone is an FDA-approved antiarrhythmic drug used for the treatment and prevention of various cardiac arrhythmias.",
    "original_searched": "Amiodarone"
  },
  "flecainide": {
    "is_drug": true,
    "reason": "Search results indicate Flecainide is an anti-arrhythmic medication used to treat abnormal heart rhythms such as atrial fibrillation and ventricular tachycardias.",
    "original_searched": "Flecainide"
  },
  "platinum": {
    "is_drug": false,
    "reason": "Search results indicate 'platinum' refers to a class of chemotherapy drugs (platinum-based drugs) and regimens, not a specific drug or regimen itself.",
    "original_searched": "Platinum"
  },
  "cd19-car-t cell": {
    "is_drug": true,
    "reason": "Search results indicate that CD19-CAR-T Cell therapy is an FDA-approved chimeric antigen receptor T-cell therapy used for treating B-cell malignancies.",
    "original_searched": "CD19-CAR-T Cell"
  },
  "isatuximab": {
    "is_drug": true,
    "reason": "Search results indicate Isatuximab is an FDA-approved drug used in combination therapy for the treatment of multiple myeloma.",
    "original_searched": "Isatuximab"
  },
  "r": {
    "is_drug": false,
    "reason": "Search results do not provide clear evidence that 'R' is a drug or therapeutic agent; the letter 'R' is not identified as a specific drug or regimen in the search results.",
    "original_searched": "R"
  },
  "rd": {
    "is_drug": true,
    "reason": "Search results indicate that Rd refers to the combination of Revlimid\u00ae (lenalidomide) and dexamethasone, which is described as a treatment regimen administered to patients.",
    "original_searched": "rd"
  },
  "ixazomib": {
    "is_drug": true,
    "reason": "Search results indicate ixazomib (Ninlaro) is an FDA-approved oral proteasome inhibitor used for the treatment of multiple myeloma.",
    "original_searched": "Ixazomib"
  },
  "voriconazole": {
    "is_drug": true,
    "reason": "Search results indicate Voriconazole is an FDA-approved antifungal medication used for the treatment of invasive fungal infections such as aspergillosis and candidemia.",
    "original_searched": "Voriconazole"
  },
  "isavuconazole": {
    "is_drug": true,
    "reason": "Search results indicate isavuconazole is a broad-spectrum triazole antifungal drug approved for the treatment of invasive fungal infections.",
    "original_searched": "Isavuconazole"
  },
  "posaconazole": {
    "is_drug": true,
    "reason": "Search results indicate Posaconazole is a triazole antifungal drug used to treat and prevent serious fungal infections, with regulatory approval for these indications.",
    "original_searched": "Posaconazole"
  },
  "imatinib": {
    "is_drug": true,
    "reason": "Search results indicate Imatinib is an FDA-approved targeted cancer drug (BCR-ABL tyrosine kinase inhibitor) used to treat several types of leukemia and other cancers.",
    "original_searched": "Imatinib"
  },
  "ponatinib": {
    "is_drug": true,
    "reason": "Search results indicate Ponatinib is an FDA-approved small molecule drug used for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.",
    "original_searched": "Ponatinib"
  },
  "ibrutinib": {
    "is_drug": true,
    "reason": "Search results indicate Ibrutinib is an FDA-approved kinase inhibitor used to treat various blood cancers and chronic graft versus host disease.",
    "original_searched": "Ibrutinib"
  },
  "sonrotoclax": {
    "is_drug": true,
    "reason": "Search results indicate that Sonrotoclax is a next-generation BCL2 inhibitor, has received orphan drug designation from the FDA, and is under priority review for the treatment of certain cancers.",
    "original_searched": "Sonrotoclax"
  },
  "methotrexate": {
    "is_drug": true,
    "reason": "Search results indicate Methotrexate is a medication used to treat inflammatory conditions and cancer, with FDA labeling and multiple sources describing its therapeutic use.",
    "original_searched": "Methotrexate"
  },
  "etentamig": {
    "is_drug": true,
    "reason": "Search results consistently describe Etentamig as an investigational immunotherapeutic drug being developed for the treatment of relapsed/refractory multiple myeloma.",
    "original_searched": "Etentamig"
  },
  "pirtobrutinib": {
    "is_drug": true,
    "reason": "Search results indicate Pirtobrutinib (Jaypirca) is an FDA-approved drug used to treat mantle cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma.",
    "original_searched": "Pirtobrutinib"
  },
  "bgb-16673": {
    "is_drug": true,
    "reason": "Search results indicate BGB-16673 is a novel drug with FDA fast track designation for treating chronic lymphocytic leukemia and small lymphocytic lymphoma, and is being studied as an anticancer agent.",
    "original_searched": "BGB-16673"
  },
  "blinatumomab": {
    "is_drug": true,
    "reason": "Search results indicate Blinatumomab is an FDA-approved antineoplastic antibody used to treat CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL).",
    "original_searched": "Blinatumomab"
  },
  "hyper-cvad": {
    "is_drug": true,
    "reason": "Search results consistently describe hyper-CVAD as a chemotherapy regimen composed of multiple drugs used to treat leukemia and lymphoma.",
    "original_searched": "hyper-CVAD"
  },
  "tirabrutinib": {
    "is_drug": true,
    "reason": "Search results indicate Tirabrutinib has received orphan drug designation from the FDA and is being studied as a therapy for primary central nervous system lymphoma.",
    "original_searched": "Tirabrutinib"
  },
  "temozolomide": {
    "is_drug": true,
    "reason": "Search results indicate Temozolomide is a chemotherapy drug (alkylating agent) used to treat glioblastoma and other cancers, with references to its use, mechanism, and brand names.",
    "original_searched": "Temozolomide"
  },
  "elranatamab": {
    "is_drug": true,
    "reason": "Search results indicate Elranatamab is an FDA-approved targeted therapy drug (bispecific T-cell engager) used to treat multiple myeloma.",
    "original_searched": "Elranatamab"
  },
  "golcadomide": {
    "is_drug": true,
    "reason": "Search results indicate Golcadomide is an oral CELMoD agent and investigational drug in development for lymphoma, administered alone or with rituximab in clinical trials.",
    "original_searched": "Golcadomide"
  },
  "car-t cell": {
    "is_drug": true,
    "reason": "Search results indicate CAR-T Cell therapy is an FDA-approved treatment for multiple hematologic malignancies and is described as a therapeutic agent administered to patients.",
    "original_searched": "CAR-T Cell"
  },
  "teclistamab": {
    "is_drug": true,
    "reason": "Search results indicate Teclistamab is an FDA-approved bispecific T-cell engager drug used to treat multiple myeloma.",
    "original_searched": "Teclistamab"
  },
  "avd": {
    "is_drug": true,
    "reason": "Search results describe AVD as a three-drug chemotherapy regimen used in Hodgkin lymphoma, indicating it is a valid drug regimen.",
    "original_searched": "AVD"
  },
  "brentuximab vedotin": {
    "is_drug": true,
    "reason": "Search results indicate Brentuximab Vedotin is an FDA-approved antibody-drug conjugate used to treat Hodgkin lymphoma and anaplastic large cell lymphoma.",
    "original_searched": "Brentuximab Vedotin"
  },
  "abvd": {
    "is_drug": true,
    "reason": "Search results consistently describe ABVD as a four-drug chemotherapy regimen (doxorubicin, bleomycin, vinblastine, dacarbazine) used for the treatment of Hodgkin lymphoma.",
    "original_searched": "ABVD"
  },
  "fcr": {
    "is_drug": true,
    "reason": "Search results indicate FCR is a combination chemotherapy regimen consisting of fludarabine, cyclophosphamide, and rituximab, used to treat chronic lymphocytic leukaemia and some types of non-Hodgkin lymphoma.",
    "original_searched": "FCR"
  },
  "pola-r-chp": {
    "is_drug": true,
    "reason": "Search results describe pola-R-CHP as a drug combination regimen including polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone, FDA-approved for the treatment of diffuse large B-cell lymphoma.",
    "original_searched": "pola-R-CHP"
  },
  "bendamustine": {
    "is_drug": true,
    "reason": "Search results indicate Bendamustine is a chemotherapy drug used to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma, and is sold under brand names such as Treanda and Levact.",
    "original_searched": "Bendamustine"
  },
  "acalabrutinib": {
    "is_drug": true,
    "reason": "Search results indicate Acalabrutinib is an FDA- and EMA-approved drug used for the treatment of mantle cell lymphoma and chronic lymphocytic leukemia.",
    "original_searched": "Acalabrutinib"
  },
  "obinutuzumab": {
    "is_drug": true,
    "reason": "Search results indicate Obinutuzumab is an FDA-approved monoclonal antibody used as a targeted cancer drug for blood cancers such as CLL and follicular lymphoma.",
    "original_searched": "Obinutuzumab"
  },
  "desmopressin": {
    "is_drug": true,
    "reason": "Search results indicate Desmopressin is an FDA-approved medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and nocturia.",
    "original_searched": "Desmopressin"
  },
  "romiplostim": {
    "is_drug": true,
    "reason": "Search results indicate Romiplostim is an FDA-approved thrombopoietin receptor agonist used to treat thrombocytopenia.",
    "original_searched": "Romiplostim"
  },
  "avatrombopag": {
    "is_drug": true,
    "reason": "Search results indicate Avatrombopag is an FDA-approved thrombopoietin receptor agonist used to treat thrombocytopenia in adults with chronic ITP and chronic liver disease.",
    "original_searched": "Avatrombopag"
  },
  "autologous hematopoietic stem cell": {
    "is_drug": true,
    "reason": "Search results indicate that autologous hematopoietic stem cell transplantation (ASCT) is a therapeutic procedure used in the treatment of diseases such as AML, multiple myeloma, and multiple sclerosis, involving the administration of autologous hematopoietic stem cells for therapeutic purposes.",
    "original_searched": "Autologous Hematopoietic Stem Cell"
  },
  "pomalidomide": {
    "is_drug": true,
    "reason": "Search results indicate Pomalidomide is an FDA-approved anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma.",
    "original_searched": "Pomalidomide"
  },
  "idecabtagene vicleucel": {
    "is_drug": true,
    "reason": "Search results indicate Idecabtagene Vicleucel is an FDA-approved chimeric antigen receptor T-cell (CAR-T) therapy used for the treatment of relapsed or refractory multiple myeloma.",
    "original_searched": "Idecabtagene Vicleucel"
  },
  "ciltacabtagene autoleucel": {
    "is_drug": true,
    "reason": "Search results indicate ciltacabtagene autoleucel (Carvykti) is an FDA-approved CAR-T cell therapy used for the treatment of relapsed or refractory multiple myeloma.",
    "original_searched": "Ciltacabtagene Autoleucel"
  },
  "carvykti": {
    "is_drug": true,
    "reason": "Search results indicate Carvykti (ciltacabtagene autoleucel) is an FDA-approved BCMA-directed CAR-T cell therapy for multiple myeloma.",
    "original_searched": "Carvykti"
  },
  "abecma": {
    "is_drug": true,
    "reason": "Search results indicate Abecma is an FDA and EMA-approved CAR T cell immunotherapy (idecabtagene vicleucel) used for the treatment of relapsed or refractory multiple myeloma.",
    "original_searched": "Abecma"
  },
  "axicabtagene ciloleucel": {
    "is_drug": true,
    "reason": "Search results indicate axicabtagene ciloleucel is an FDA-approved CAR T-cell therapy used to treat large B-cell lymphoma and follicular lymphoma.",
    "original_searched": "Axicabtagene ciloleucel"
  },
  "tisagenlecleucel": {
    "is_drug": true,
    "reason": "Search results indicate Tisagenlecleucel is an FDA-approved CAR T-cell therapy (brand name Kymriah) used for the treatment of B-cell acute lymphoblastic leukemia.",
    "original_searched": "Tisagenlecleucel"
  },
  "azacytidine": {
    "is_drug": true,
    "reason": "Search results indicate Azacitidine is an FDA-approved drug used to treat myelodysplastic syndromes and acute myeloid leukemia.",
    "original_searched": "Azacytidine"
  },
  "decitabine": {
    "is_drug": true,
    "reason": "Search results indicate Decitabine is an FDA and EMA-approved hypomethylating agent used for the treatment of acute myeloid leukemia and myelodysplastic syndrome.",
    "original_searched": "Decitabine"
  },
  "fludarabine/cyclophosphamide": {
    "is_drug": true,
    "reason": "Search results describe Fludarabine/Cyclophosphamide as components of chemotherapy regimens used in the treatment of chronic lymphocytic leukemia and other cancers.",
    "original_searched": "Fludarabine/Cyclophosphamide"
  },
  "cemdisiran": {
    "is_drug": true,
    "reason": "Search results indicate Cemdisiran is a subcutaneously-administered small interfering RNA therapeutic in Phase 3 development for complement-mediated disorders and myasthenia gravis.",
    "original_searched": "Cemdisiran"
  },
  "pozelimab": {
    "is_drug": true,
    "reason": "Search results indicate Pozelimab is an FDA-approved drug, marketed as Veopoz, used for the treatment of CHAPLE disease.",
    "original_searched": "Pozelimab"
  },
  "ravulizumab": {
    "is_drug": true,
    "reason": "Search results indicate Ravulizumab is an FDA-approved prescription medication used to treat several diseases including myasthenia gravis, aHUS, and PNH.",
    "original_searched": "Ravulizumab"
  },
  "ruxolitinib": {
    "is_drug": true,
    "reason": "Search results indicate Ruxolitinib is an FDA-approved medication used to treat myelofibrosis, polycythemia vera, and other conditions.",
    "original_searched": "Ruxolitinib"
  },
  "flonoltinib maleate": {
    "is_drug": true,
    "reason": "Search results indicate Flonoltinib Maleate is a dual-target JAK2/FLT3 inhibitor being studied in clinical trials for myeloproliferative neoplasms, with evidence of therapeutic use.",
    "original_searched": "Flonoltinib Maleate"
  },
  "allogeneic stem cell": {
    "is_drug": true,
    "reason": "Search results indicate that allogeneic stem cell transplantation is a therapeutic procedure where donor stem cells are administered to treat diseases such as blood cancers, fulfilling the criteria for a therapeutic agent.",
    "original_searched": "Allogeneic Stem Cell"
  },
  "eltrombopag": {
    "is_drug": true,
    "reason": "Search results indicate Eltrombopag is an FDA-approved thrombopoietin receptor agonist used for the treatment of thrombocytopenia in adults and children.",
    "original_searched": "Eltrombopag"
  },
  "interferon alfa": {
    "is_drug": true,
    "reason": "Search results indicate Interferon Alfa is a pharmaceutical drug and biologic response modifier used to treat cancers and viral infections, with FDA approval mentioned.",
    "original_searched": "Interferon Alfa"
  },
  "anagrelide": {
    "is_drug": true,
    "reason": "Search results indicate Anagrelide is an FDA-approved drug used to treat essential thrombocythemia and reduce elevated platelet counts.",
    "original_searched": "Anagrelide"
  },
  "beacopp": {
    "is_drug": true,
    "reason": "Search results indicate BEACOPP is a chemotherapy regimen used to treat Hodgkin's lymphoma, consisting of multiple drugs administered therapeutically.",
    "original_searched": "Beacopp"
  },
  "nilotinib": {
    "is_drug": true,
    "reason": "Search results indicate Nilotinib is an FDA-approved kinase inhibitor used to treat Philadelphia chromosome positive chronic myelogenous leukemia (CML).",
    "original_searched": "Nilotinib"
  },
  "dasatinib": {
    "is_drug": true,
    "reason": "Search results indicate Dasatinib is an FDA-approved tyrosine kinase inhibitor used to treat chronic myeloid leukemia and acute lymphoblastic leukemia.",
    "original_searched": "Dasatinib"
  },
  "siltuximab": {
    "is_drug": true,
    "reason": "Search results indicate Siltuximab (SYLVANT) is an FDA-approved prescription medicine used to treat multicentric Castleman disease.",
    "original_searched": "Siltuximab"
  },
  "tocilizumab": {
    "is_drug": true,
    "reason": "Search results indicate Tocilizumab is an FDA-approved recombinant humanized monoclonal antibody used to treat inflammatory and autoimmune conditions, including cytokine release syndrome and rheumatoid arthritis.",
    "original_searched": "Tocilizumab"
  },
  "pacritinib": {
    "is_drug": true,
    "reason": "Search results indicate Pacritinib is an FDA-approved kinase inhibitor used for the treatment of myelofibrosis in adults.",
    "original_searched": "Pacritinib"
  },
  "hydroxyurea": {
    "is_drug": true,
    "reason": "Search results indicate Hydroxyurea is an FDA-approved oral anticancer drug used for chronic myeloid leukemia, head and neck cancers, and sickle cell anemia.",
    "original_searched": "Hydroxyurea"
  },
  "plerixafor": {
    "is_drug": true,
    "reason": "Search results indicate Plerixafor is an FDA-approved hematopoietic stem cell mobilizer used in preparation for autologous stem cell transplantation.",
    "original_searched": "Plerixafor"
  },
  "g-csf": {
    "is_drug": true,
    "reason": "Search results indicate G-CSF (Granulocyte Colony Stimulating Factor) is an indispensable drug used to treat leukopenia and neutropenia, especially in patients undergoing chemotherapy.",
    "original_searched": "G-CSF"
  },
  "motixafortide": {
    "is_drug": true,
    "reason": "Search results indicate Motixafortide is an FDA-approved prescription medication used in combination with filgrastim to mobilize hematopoietic stem cells for autologous transplantation in patients with multiple myeloma.",
    "original_searched": "Motixafortide"
  },
  "autologous car19/22": {
    "is_drug": true,
    "reason": "Search results describe autologous CAR19/22 as a dual-targeting CAR-T cell therapy (targeting CD19 and CD22) used for treatment of B-cell malignancies, indicating it is a therapeutic agent administered to patients.",
    "original_searched": "autologous CAR19/22"
  },
  "orca-t-allogeneic car19/22": {
    "is_drug": true,
    "reason": "Search results indicate Orca-T is an investigational allogeneic T-cell immunotherapy, and CAR19/22 refers to donor-derived CD19/CD22-CAR T cells administered therapeutically for hematologic malignancies.",
    "original_searched": "Orca-T-allogeneic CAR19/22"
  },
  "cvp": {
    "is_drug": true,
    "reason": "Search results indicate CVP is a chemotherapy regimen consisting of cyclophosphamide, vincristine, and prednisone, used to treat non-Hodgkin lymphoma.",
    "original_searched": "CVP"
  },
  "chop": {
    "is_drug": true,
    "reason": "Search results consistently describe CHOP as a chemotherapy regimen combining cyclophosphamide, doxorubicin, vincristine, and prednisone, used for treating non-Hodgkin lymphoma.",
    "original_searched": "CHOP"
  },
  "allogeneic hematopoietic cell": {
    "is_drug": false,
    "reason": "Search results indicate 'Allogeneic Hematopoietic Cell' refers to a type of stem cell used in transplantation procedures, not a specific drug or drug regimen.",
    "original_searched": "Allogeneic Hematopoietic Cell"
  },
  "hypomethylating agent": {
    "is_drug": false,
    "reason": "Search results indicate 'hypomethylating agent' refers to a class of drugs (such as azacitidine and decitabine), not a specific drug or regimen.",
    "original_searched": "Hypomethylating Agent"
  },
  "inotuzumab ozogamicin": {
    "is_drug": true,
    "reason": "Search results indicate Inotuzumab ozogamicin is an FDA-approved antibody-drug conjugate used for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia.",
    "original_searched": "Inotuzumab ozogamicin"
  },
  "melphalan": {
    "is_drug": true,
    "reason": "Search results indicate Melphalan is a chemotherapy drug used to treat multiple myeloma and as a conditioning regimen for stem cell transplantation.",
    "original_searched": "Melphalan"
  },
  "anitocabtagene autoleucel": {
    "is_drug": true,
    "reason": "Search results indicate Anitocabtagene Autoleucel is a BCMA-directed CAR T-cell therapy in development for multiple myeloma, described as an autologous chimeric antigen receptor T-cell therapy used for treatment.",
    "original_searched": "Anitocabtagene Autoleucel"
  },
  "orelabrutinib": {
    "is_drug": true,
    "reason": "Search results indicate Orelabrutinib is a small molecule drug approved in China for mantle cell lymphoma and chronic lymphocytic leukemia, and is under investigation for multiple sclerosis and other autoimmune diseases.",
    "original_searched": "Orelabrutinib"
  },
  "azacitidine": {
    "is_drug": true,
    "reason": "Search results indicate Azacitidine is an FDA-approved drug used to treat acute myeloid leukemia and myelodysplastic syndromes.",
    "original_searched": "Azacitidine"
  },
  "autologous hematopoietic cell": {
    "is_drug": false,
    "reason": "Search results indicate 'Autologous Hematopoietic Cell' refers to a type of cell used in transplantation procedures, not a drug or drug regimen.",
    "original_searched": "Autologous Hematopoietic Cell"
  },
  "haploidentical donor hematopoietic cell": {
    "is_drug": false,
    "reason": "Search results indicate 'Haploidentical Donor Hematopoietic Cell' refers to a type of donor used in hematopoietic cell transplantation, not a specific drug or therapeutic agent.",
    "original_searched": "Haploidentical Donor Hematopoietic Cell"
  },
  "enasidenib": {
    "is_drug": true,
    "reason": "Search results indicate Enasidenib (Idhifa) is an FDA-approved drug for the treatment of relapsed or refractory acute myeloid leukemia (AML).",
    "original_searched": "Enasidenib"
  },
  "astx727": {
    "is_drug": true,
    "reason": "Search results indicate ASTX727 is a combination of decitabine and cedazuridine, granted Orphan Drug Designation and used in clinical trials for treatment of hematologic malignancies.",
    "original_searched": "ASTX727"
  },
  "allogeneic hematopoietic stem cell": {
    "is_drug": true,
    "reason": "Search results indicate that allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a therapeutic procedure used to treat various diseases, and allogeneic hematopoietic stem cells are administered as part of this treatment.",
    "original_searched": "Allogeneic Hematopoietic Stem Cell"
  },
  "tacrolimus": {
    "is_drug": true,
    "reason": "Search results indicate Tacrolimus is an FDA-approved immunosuppressant drug used to prevent organ transplant rejection and treat atopic dermatitis.",
    "original_searched": "Tacrolimus"
  },
  "orca-t": {
    "is_drug": true,
    "reason": "Search results indicate Orca-T is an investigational allogeneic T-cell immunotherapy undergoing FDA review and clinical trials for the treatment of hematological malignancies.",
    "original_searched": "Orca-T"
  },
  "flumatinib": {
    "is_drug": true,
    "reason": "Search results indicate Flumatinib is an approved oral BCR-ABL1 tyrosine kinase inhibitor used for the treatment of chronic myeloid leukemia.",
    "original_searched": "Flumatinib"
  },
  "cyclosporine": {
    "is_drug": true,
    "reason": "Search results indicate Cyclosporine is an FDA-approved oral systemic drug used to prevent transplant rejection and treat conditions like psoriasis and rheumatoid arthritis.",
    "original_searched": "Cyclosporine"
  },
  "fludarabine": {
    "is_drug": true,
    "reason": "Search results indicate Fludarabine is an FDA-approved antimetabolite drug used to treat cancers such as chronic lymphocytic leukemia and is listed as an essential medicine by the WHO.",
    "original_searched": "Fludarabine"
  },
  "givinostat": {
    "is_drug": true,
    "reason": "Search results indicate Givinostat is an FDA-approved nonsteroidal drug used for the treatment of Duchenne Muscular Dystrophy.",
    "original_searched": "Givinostat"
  },
  "cladribine": {
    "is_drug": true,
    "reason": "Search results indicate Cladribine is an FDA and EMA approved oral drug used for treating multiple sclerosis and as chemotherapy for leukemia and lymphoma.",
    "original_searched": "Cladribine"
  },
  "cpx-351": {
    "is_drug": true,
    "reason": "Search results indicate CPX-351 is a liposomal formulation of cytarabine and daunorubicin, and is FDA-approved for the treatment of AML.",
    "original_searched": "CPX-351"
  },
  "cytarabine": {
    "is_drug": true,
    "reason": "Search results indicate Cytarabine is an FDA-approved chemotherapy medication used to treat various types of leukemia.",
    "original_searched": "Cytarabine"
  },
  "mitoxantrone": {
    "is_drug": true,
    "reason": "Search results indicate Mitoxantrone is an FDA-approved chemotherapy drug used to treat cancer and multiple sclerosis.",
    "original_searched": "Mitoxantrone"
  },
  "da-epoch-r": {
    "is_drug": true,
    "reason": "Search results indicate DA-EPOCH-R is a combination chemotherapy regimen consisting of FDA-approved drugs used to treat lymphoma.",
    "original_searched": "DA-EPOCH-R"
  },
  "r-epoch": {
    "is_drug": true,
    "reason": "Search results indicate R-EPOCH is a multi-drug chemotherapy regimen used to treat aggressive B-cell lymphomas, consisting of rituximab and other chemotherapy agents.",
    "original_searched": "R-EPOCH"
  },
  "7+3": {
    "is_drug": true,
    "reason": "Search results indicate that '7+3' is a chemotherapy regimen consisting of cytarabine and an anthracycline (such as daunorubicin) used for the treatment of acute myeloid leukemia.",
    "original_searched": "7+3"
  },
  "idarubicin": {
    "is_drug": true,
    "reason": "Search results indicate Idarubicin is an FDA-approved drug used in combination chemotherapy for acute myeloid leukemia.",
    "original_searched": "Idarubicin"
  },
  "daunorubicin": {
    "is_drug": true,
    "reason": "Search results indicate Daunorubicin is an FDA-approved chemotherapy medication used to treat cancer, specifically as an antineoplastic agent for remission induction in leukemia.",
    "original_searched": "Daunorubicin"
  },
  "cag": {
    "is_drug": true,
    "reason": "Search results indicate that CAG is a chemotherapy regimen composed of cytarabine, aclarubicin, and granulocyte colony-stimulating factor, used for treating refractory hematologic malignancies.",
    "original_searched": "CAG"
  },
  "chidamide": {
    "is_drug": true,
    "reason": "Search results indicate Chidamide is an oral HDAC inhibitor approved by the China Food and Drug Administration for the treatment of lymphomas.",
    "original_searched": "Chidamide"
  },
  "carfilzomib": {
    "is_drug": true,
    "reason": "Search results indicate Carfilzomib is an FDA-approved chemotherapy drug (proteasome inhibitor) used to treat blood cancer, specifically multiple myeloma.",
    "original_searched": "Carfilzomib"
  },
  "nivolumab": {
    "is_drug": true,
    "reason": "Search results indicate Nivolumab is an FDA-approved immunotherapy drug (immune checkpoint inhibitor) used for cancer treatment.",
    "original_searched": "Nivolumab"
  },
  "brecadd": {
    "is_drug": true,
    "reason": "Search results indicate BrECADD is a treatment regimen, specifically an ADCETRIS (brentuximab vedotin)-based combination, approved and recommended for advanced-stage classical Hodgkin lymphoma.",
    "original_searched": "brecadd"
  },
  "ebeacopp": {
    "is_drug": true,
    "reason": "Search results consistently describe BEACOPP as a chemotherapy regimen combining multiple drugs for the treatment of Hodgkin's lymphoma.",
    "original_searched": "ebeacopp"
  },
  "brentuximab": {
    "is_drug": true,
    "reason": "Search results indicate Brentuximab (specifically Brentuximab vedotin) is an FDA-approved antibody-drug conjugate used to treat Hodgkin lymphoma and anaplastic large cell lymphoma.",
    "original_searched": "Brentuximab"
  },
  "liposomal mitoxantrone": {
    "is_drug": true,
    "reason": "Search results indicate liposomal mitoxantrone is a modified drug formulation used in chemotherapy regimens and has demonstrated efficacy in treating hematologic malignancies.",
    "original_searched": "Liposomal mitoxantrone"
  },
  "selinexor": {
    "is_drug": true,
    "reason": "Search results indicate Selinexor is an FDA-approved cancer drug, marketed as Xpovio, and used in the treatment of multiple myeloma.",
    "original_searched": "Selinexor"
  },
  "rvd": {
    "is_drug": true,
    "reason": "Search results indicate RVd (also written as VRd) is a three-drug regimen consisting of lenalidomide, bortezomib, and dexamethasone used as therapy for multiple myeloma.",
    "original_searched": "RVd"
  },
  "treosulfan": {
    "is_drug": true,
    "reason": "Search results indicate Treosulfan is an FDA-approved alkylating agent used in combination with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation.",
    "original_searched": "Treosulfan"
  },
  "busulfan": {
    "is_drug": true,
    "reason": "Search results indicate Busulfan is an FDA-approved bifunctional alkylating agent used therapeutically, including as part of conditioning regimens for stem cell transplantation.",
    "original_searched": "Busulfan"
  },
  "thiotepa": {
    "is_drug": true,
    "reason": "Search results indicate Thiotepa is a chemotherapy drug and alkylating agent used to treat various cancers and prevent graft rejection.",
    "original_searched": "Thiotepa"
  },
  "hematopoietic stem cell": {
    "is_drug": true,
    "reason": "Search results indicate hematopoietic stem cells are used therapeutically in transplantation and gene therapy for treating malignant and nonmalignant diseases.",
    "original_searched": "Hematopoietic Stem Cell"
  },
  "clag": {
    "is_drug": true,
    "reason": "Search results indicate CLAG is a chemotherapy regimen consisting of cladribine, cytarabine, and filgrastim, used as an effective therapy for relapsed/refractory acute myeloid leukemia.",
    "original_searched": "CLAG"
  },
  "flag": {
    "is_drug": true,
    "reason": "Search results indicate FLAG is a chemotherapy regimen combining fludarabine, cytarabine, and G-CSF, used for the treatment of acute myeloid leukemia.",
    "original_searched": "FLAG"
  },
  "3+7": {
    "is_drug": false,
    "reason": "Search results discuss the '7+3' regimen as a chemotherapy protocol for AML, but there is no evidence that '3+7' is a recognized drug or regimen; the results do not confirm '3+7' as a therapeutic agent.",
    "original_searched": "3+7"
  },
  "midostaurin": {
    "is_drug": true,
    "reason": "Search results indicate Midostaurin is an FDA and EMA-approved drug used in combination with chemotherapy for FLT3-mutated AML and as monotherapy for other conditions.",
    "original_searched": "Midostaurin"
  },
  "avapritinib": {
    "is_drug": true,
    "reason": "Search results indicate Avapritinib is an FDA-approved tyrosine kinase inhibitor used for the treatment of gastrointestinal stromal tumor (GIST) with PDGFRA exon 18 mutations and advanced systemic mastocytosis.",
    "original_searched": "Avapritinib"
  },
  "mycophenolate mofetil": {
    "is_drug": true,
    "reason": "Search results indicate Mycophenolate Mofetil is an FDA-approved immunosuppressive drug used to prevent organ rejection and treat autoimmune diseases.",
    "original_searched": "Mycophenolate Mofetil"
  },
  "rituximab-chop": {
    "is_drug": true,
    "reason": "Search results consistently describe rituximab-CHOP (R-CHOP) as a chemotherapy regimen combining rituximab with CHOP drugs for the treatment of non-Hodgkin lymphoma and diffuse large B-cell lymphoma.",
    "original_searched": "rituximab-CHOP"
  },
  "atra-rif": {
    "is_drug": true,
    "reason": "Search results indicate ATRA-RIF is a therapeutic regimen combining all-trans retinoic acid (ATRA) with realgar-indigo naturalis formula (RIF) used in the treatment of acute promyelocytic leukemia.",
    "original_searched": "ATRA-RIF"
  },
  "dapolsertib": {
    "is_drug": true,
    "reason": "Search results indicate Dapolsertib is a dual FLT3/PIM inhibitor being evaluated in clinical trials for AML and DLBCL, and is recognized as an INN by the WHO, confirming it as a therapeutic agent.",
    "original_searched": "Dapolsertib"
  },
  "sintilimab": {
    "is_drug": true,
    "reason": "Search results indicate Sintilimab is a selective anti\u2013PD-1 antibody used therapeutically in cancer treatment, and is included in China's National Reimbursement Drug List for approved indications.",
    "original_searched": "Sintilimab"
  },
  "crizanlizumab": {
    "is_drug": true,
    "reason": "Search results indicate Crizanlizumab is an FDA-approved drug (Adakveo) used to reduce vaso-occlusive crises in sickle cell disease.",
    "original_searched": "Crizanlizumab"
  },
  "mesutoclax": {
    "is_drug": false,
    "reason": "Search results only mention venetoclax and related regimens, with no information or evidence that Mesutoclax is a drug or therapeutic agent.",
    "original_searched": "Mesutoclax"
  },
  "hydroxycarbamide": {
    "is_drug": true,
    "reason": "Search results indicate Hydroxycarbamide (also known as hydroxyurea) is an FDA-approved antimetabolite medication used to treat sickle cell disease and various cancers.",
    "original_searched": "Hydroxycarbamide"
  },
  "gemtuzumab ozogamycin": {
    "is_drug": true,
    "reason": "Search results indicate Gemtuzumab Ozogamicin is an FDA-approved antibody-drug conjugate (sold as Mylotarg) used for the treatment of acute myeloid leukemia.",
    "original_searched": "Gemtuzumab Ozogamycin"
  },
  "natalizumab": {
    "is_drug": true,
    "reason": "Search results indicate Natalizumab is an FDA-approved biologic medication used to treat multiple sclerosis and Crohn's disease.",
    "original_searched": "Natalizumab"
  },
  "brexucabtagene autoleucel": {
    "is_drug": true,
    "reason": "Search results indicate Brexucabtagene autoleucel is an FDA-approved drug for the treatment of mantle cell lymphoma and B-cell precursor acute lymphoblastic leukemia.",
    "original_searched": "Brexucabtagene autoleucel"
  },
  "iadademstat": {
    "is_drug": true,
    "reason": "Search results indicate Iadademstat has received FDA and EMA orphan drug designation for AML, is described as an oral medication and epigenetic drug, and is being studied in clinical trials for therapeutic use.",
    "original_searched": "Iadademstat"
  },
  "lyt-200": {
    "is_drug": true,
    "reason": "Search results indicate LYT-200 is an investigational drug that has received FDA Fast Track and Orphan Drug designations for the treatment of acute myeloid leukemia.",
    "original_searched": "Lyt-200"
  },
  "hma": {
    "is_drug": true,
    "reason": "Search results consistently describe HMA as 'hypomethylating agents,' a class of drugs (including azacitidine and decitabine) used therapeutically for myelodysplastic syndrome and acute myeloid leukemia.",
    "original_searched": "HMA"
  },
  "abt-199": {
    "is_drug": true,
    "reason": "Search results indicate ABT-199 (Venetoclax) is an FDA-approved small molecule BCL-2 inhibitor used for the treatment of chronic lymphocytic leukemia.",
    "original_searched": "ABT-199"
  },
  "ctx-712": {
    "is_drug": true,
    "reason": "Search results indicate CTX-712 is a novel CLK inhibitor being studied in phase I clinical trials for cancer, with evidence of anti-tumor efficacy and administration to patients.",
    "original_searched": "CTX-712"
  },
  "wj01024": {
    "is_drug": false,
    "reason": "Search results do not provide clear evidence that WJ01024 is a drug or therapeutic agent; the only mention is in the context of a combination therapy without further details, and other results are unrelated.",
    "original_searched": "WJ01024"
  },
  "romaciclib": {
    "is_drug": false,
    "reason": "Search results only mention ribociclib, a known CDK4/6 inhibitor, and do not provide any evidence that 'romaciclib' is a valid drug or therapeutic agent.",
    "original_searched": "romaciclib"
  },
  "rvu120": {
    "is_drug": true,
    "reason": "Search results indicate RVU120 is a CDK8/19 inhibitor being administered in clinical trials as a medicine for AML, MDS, and myelofibrosis, with dosing and efficacy data described.",
    "original_searched": "RVU120"
  },
  "abatacept": {
    "is_drug": true,
    "reason": "Search results indicate Abatacept is an FDA-approved biological disease-modifying antirheumatic drug (DMARD) used for the treatment of rheumatoid arthritis and other rheumatic conditions.",
    "original_searched": "Abatacept"
  },
  "phytosphingosine": {
    "is_drug": false,
    "reason": "Search results indicate phytosphingosine is used in cosmetics and skincare products for topical application, with no evidence it is an approved drug or therapeutic agent.",
    "original_searched": "Phytosphingosine"
  },
  "bcma-directed car-t cell": {
    "is_drug": true,
    "reason": "Search results indicate BCMA-Directed CAR-T Cell therapies are FDA-approved cellular immunotherapies used to treat multiple myeloma.",
    "original_searched": "BCMA-Directed CAR-T Cell"
  },
  "phenlyacetylglycine": {
    "is_drug": false,
    "reason": "Search results describe phenylacetylglycine as a gut microbial metabolite and mention its potential as a therapeutic agent, but do not provide evidence of it being an approved drug, investigational drug, or established therapeutic regimen.",
    "original_searched": "Phenlyacetylglycine"
  },
  "18f-fdg": {
    "is_drug": true,
    "reason": "Search results indicate 18F-FDG (Fludeoxyglucose F 18) is a radiopharmaceutical used in PET imaging and is provided as an injectable pharmaceutical product.",
    "original_searched": "18F-FDG"
  },
  "ird": {
    "is_drug": true,
    "reason": "Search results consistently describe IRD as a three-drug regimen consisting of ixazomib, lenalidomide, and dexamethasone used therapeutically in clinical studies.",
    "original_searched": "IRD"
  },
  "drd": {
    "is_drug": true,
    "reason": "Search results indicate DRd refers to a drug regimen combining daratumumab, lenalidomide (Revlimid), and dexamethasone, used as anti-myeloma therapy.",
    "original_searched": "DRD"
  },
  "hfe mrna": {
    "is_drug": false,
    "reason": "Search results indicate HFE mRNA refers to the messenger RNA of the HFE gene, which is involved in iron regulation, but do not provide evidence that it is a drug or therapeutic agent.",
    "original_searched": "HFE mRNA"
  },
  "emactuzumab": {
    "is_drug": true,
    "reason": "Search results indicate Emactuzumab is a humanized monoclonal antibody targeting CSF1R, used in clinical studies and investigated for treatment of solid tumors.",
    "original_searched": "Emactuzumab"
  },
  "encorafenib": {
    "is_drug": true,
    "reason": "Search results indicate Encorafenib is an FDA-approved kinase inhibitor used to treat unresectable or metastatic melanoma and colorectal cancer.",
    "original_searched": "Encorafenib"
  },
  "folfiri": {
    "is_drug": true,
    "reason": "Search results describe FOLFIRI as a chemotherapy regimen consisting of folinic acid, fluorouracil, and irinotecan, used in the treatment of various cancers.",
    "original_searched": "FOLFIRI"
  },
  "cetuximab": {
    "is_drug": true,
    "reason": "Search results indicate Cetuximab (Erbitux) is an FDA-approved anti-cancer drug used for the treatment of metastatic colorectal cancer and head and neck cancer.",
    "original_searched": "Cetuximab"
  },
  "liposomal irinotecan": {
    "is_drug": true,
    "reason": "Search results indicate that liposomal irinotecan (Onivyde) is FDA-approved for use in chemotherapy regimens for pancreatic cancer, confirming it is a valid therapeutic drug.",
    "original_searched": "Liposomal Irinotecan"
  },
  "5-fluorouracil": {
    "is_drug": true,
    "reason": "Search results indicate 5-Fluorouracil (5-FU) is an approved chemotherapy drug used to treat various cancers and is administered intravenously.",
    "original_searched": "5-Fluorouracil"
  },
  "folinic acid": {
    "is_drug": true,
    "reason": "Search results indicate folinic acid (also known as leucovorin) is an FDA-approved medication used to reduce the toxic effects of methotrexate and as part of chemotherapy regimens.",
    "original_searched": "Folinic Acid"
  },
  "ibi343": {
    "is_drug": true,
    "reason": "Search results indicate IBI343 is a monoclonal antibody-drug conjugate developed by Innovent Biologics, with FDA fast track designation for treatment of advanced pancreatic cancer and clinical trial data supporting its therapeutic use.",
    "original_searched": "IBI343"
  },
  "arcotatug tavatecan": {
    "is_drug": true,
    "reason": "Search results indicate that arcotatug tavatecan is an anti-CLDN18.2 antibody-drug conjugate (ADC) in phase III trials, suggesting it is an investigational therapeutic agent.",
    "original_searched": "Arcotatug Tavatecan"
  },
  "durvalumab": {
    "is_drug": true,
    "reason": "Search results indicate Durvalumab (Imfinzi) is an FDA-approved drug used in combination with chemotherapy for the treatment of lung and urothelial cancers.",
    "original_searched": "Durvalumab"
  },
  "bevacizumab": {
    "is_drug": true,
    "reason": "Search results indicate Bevacizumab is an FDA-approved anti-angiogenic drug and monoclonal antibody used in cancer treatment.",
    "original_searched": "Bevacizumab"
  },
  "transarterial radioembolization": {
    "is_drug": false,
    "reason": "Search results indicate Transarterial Radioembolization is a procedure or form of radiation therapy (using agents like Yttrium-90), not a specific drug or drug regimen.",
    "original_searched": "Transarterial Radioembolization"
  },
  "aumolertinib": {
    "is_drug": true,
    "reason": "Search results indicate Aumolertinib is an approved pharmaceutical drug for the treatment of non-small cell lung cancer, with regulatory approval by MHRA and use as a targeted therapy.",
    "original_searched": "Aumolertinib"
  },
  "domvanalimab": {
    "is_drug": true,
    "reason": "Search results indicate Domvanalimab is a TIGIT-blocker drug under investigation in multiple clinical trials for cancer treatment, and is described as part of combination regimens with chemotherapy.",
    "original_searched": "Domvanalimab"
  },
  "zimberelimab": {
    "is_drug": true,
    "reason": "Search results indicate Zimberelimab is a fully human anti-PD-1 monoclonal antibody that has been approved for marketing in China for the treatment of relapsed or refractory classical Hodgkin's lymphoma.",
    "original_searched": "Zimberelimab"
  },
  "bnt327/pm8002": {
    "is_drug": true,
    "reason": "Search results indicate BNT327/PM8002 is a bispecific antibody drug targeting PD-L1 and VEGF, being tested in clinical trials as an immunotherapy for various cancers.",
    "original_searched": "BNT327/PM8002"
  },
  "lenvatinib": {
    "is_drug": true,
    "reason": "Search results indicate lenvatinib is an FDA-approved targeted cancer treatment (brand name Lenvima) used for thyroid cancer, hepatocellular carcinoma, renal cell carcinoma, and endometrial carcinoma.",
    "original_searched": "Lenvatinib"
  },
  "pembrolizumab": {
    "is_drug": true,
    "reason": "Search results indicate Pembrolizumab is an FDA-approved immunotherapy drug (checkpoint inhibitor) used for the treatment of various cancers.",
    "original_searched": "Pembrolizumab"
  },
  "avelumab": {
    "is_drug": true,
    "reason": "Search results indicate Avelumab is an FDA-approved immune checkpoint inhibitor used for the treatment of metastatic Merkel cell carcinoma and urothelial carcinoma.",
    "original_searched": "Avelumab"
  },
  "shr-a1811": {
    "is_drug": true,
    "reason": "Search results describe SHR-A1811 as a third-generation antibody-drug conjugate with antitumor activity, used in clinical trials for cancer treatment.",
    "original_searched": "SHR-A1811"
  },
  "mhb088c": {
    "is_drug": true,
    "reason": "Search results indicate MHB088C is a novel antibody-drug conjugate (ADC) targeting B7-H3, administered intravenously in clinical trials as a therapeutic agent.",
    "original_searched": "MHB088C"
  },
  "envafolimab": {
    "is_drug": true,
    "reason": "Search results indicate Envafolimab is an approved anti-PD-L1 antibody used in cancer immunotherapy, with orphan drug designation from the US FDA and approval in China for specific cancer indications.",
    "original_searched": "Envafolimab"
  },
  "nepa": {
    "is_drug": true,
    "reason": "Search results indicate NEPA is a fixed-dose combination of netupitant and palonosetron used as an antiemetic regimen for the prevention of chemotherapy-induced nausea and vomiting.",
    "original_searched": "NEPA"
  },
  "vimseltinib": {
    "is_drug": true,
    "reason": "Search results indicate Vimseltinib is an FDA-approved kinase inhibitor used for the treatment of tenosynovial giant cell tumor.",
    "original_searched": "Vimseltinib"
  },
  "imm2510": {
    "is_drug": true,
    "reason": "Search results indicate IMM2510 is an investigational bispecific antibody targeting VEGF and PD-L1, being studied in clinical trials for the treatment of solid tumors and NSCLC.",
    "original_searched": "IMM2510"
  },
  "cabozantinib": {
    "is_drug": true,
    "reason": "Search results indicate Cabozantinib is an FDA-approved kinase inhibitor used for the treatment of various cancers, including medullary thyroid cancer and neuroendocrine tumors.",
    "original_searched": "Cabozantinib"
  },
  "st-001": {
    "is_drug": true,
    "reason": "Search results indicate ST-001 is an investigational drug (nanoFenretinide) with an FDA-approved IND application, used as intravenous therapy in clinical trials for relapsed/refractory small cell lung cancer.",
    "original_searched": "ST-001"
  },
  "fenretinide": {
    "is_drug": true,
    "reason": "Search results describe Fenretinide as a synthetic retinoid and anticancer agent investigated for cancer treatment and prevention.",
    "original_searched": "Fenretinide"
  },
  "ibi354": {
    "is_drug": true,
    "reason": "Search results indicate IBI354 is an anti-HER2 antibody-drug conjugate developed by Innovent Biologics, tested in clinical trials for cancer treatment.",
    "original_searched": "IBI354"
  },
  "toripalimab": {
    "is_drug": true,
    "reason": "Search results indicate Toripalimab is an FDA-approved immunotherapy agent (PD-1 antibody) used for the treatment of melanoma and nasopharyngeal carcinoma.",
    "original_searched": "Toripalimab"
  },
  "dnv3": {
    "is_drug": false,
    "reason": "Search results do not mention DNV3 as a drug or drug regimen; they discuss other HIV regimens such as dolutegravir/lamivudine and darunavir/ritonavir, but there is no evidence that DNV3 is a therapeutic agent.",
    "original_searched": "DNV3"
  },
  "64cu-sar-bispsma": {
    "is_drug": true,
    "reason": "Search results indicate 64Cu-SAR-bisPSMA has received FDA Fast Track Designation for PET imaging and is described as safe and effective in clinical trials, confirming its use as a therapeutic/diagnostic agent.",
    "original_searched": "64Cu-SAR-bisPSMA"
  },
  "[225ac]ac-fl-020": {
    "is_drug": true,
    "reason": "Search results indicate that [225Ac]Ac-FL-020 is an investigational PSMA-targeting radionuclide drug conjugate with FDA fast track designation for the treatment of metastatic castration-resistant prostate cancer.",
    "original_searched": "[225Ac]Ac-FL-020"
  },
  "serplulimab": {
    "is_drug": true,
    "reason": "Search results indicate Serplulimab is an anti-PD-1 monoclonal antibody that has received FDA orphan drug designation and EU approval for the treatment of small cell lung cancer.",
    "original_searched": "Serplulimab"
  },
  "precemtabart tocentecan": {
    "is_drug": true,
    "reason": "Search results indicate Precemtabart tocentecan is an antibody-drug conjugate (ADC) developed by Merck KGaA, showing antitumor activity and advancing to Phase III trials for colorectal cancer.",
    "original_searched": "Precemtabart tocentecan"
  },
  "m9140": {
    "is_drug": true,
    "reason": "Search results indicate M9140 is an anti-CEACAM5 antibody drug conjugate (ADC) being investigated in clinical trials for metastatic colorectal cancer, with dosing and administration details provided.",
    "original_searched": "M9140"
  },
  "tarlatamab": {
    "is_drug": true,
    "reason": "Search results indicate Tarlatamab is an FDA-approved targeted immunotherapy drug used to treat small cell lung cancer.",
    "original_searched": "Tarlatamab"
  },
  "epcoritamab": {
    "is_drug": true,
    "reason": "Search results indicate Epcoritamab is an FDA-approved bispecific T-cell engager drug (brand name Epkinly) used in the treatment of lymphoma.",
    "original_searched": "Epcoritamab"
  },
  "datopotamab deruxtecan": {
    "is_drug": true,
    "reason": "Search results indicate Datopotamab Deruxtecan is an FDA-approved antibody drug conjugate used for the treatment of certain types of breast and lung cancer.",
    "original_searched": "Datopotamab Deruxtecan"
  },
  "vorasidenib": {
    "is_drug": true,
    "reason": "Search results indicate Vorasidenib is an FDA-approved oral medication and targeted therapy for low-grade gliomas, with explicit mentions of its use as a treatment for brain tumors.",
    "original_searched": "Vorasidenib"
  },
  "ptcy": {
    "is_drug": true,
    "reason": "Search results indicate PTCy stands for post-transplant cyclophosphamide, which is used as a therapeutic regimen for GVHD prophylaxis in transplant patients.",
    "original_searched": "PTCy"
  },
  "bexmarilimab": {
    "is_drug": true,
    "reason": "Search results indicate Bexmarilimab is a novel immunotherapy drug in clinical trials for myelodysplastic syndromes, with FDA endorsement for accelerated approval as a treatment option.",
    "original_searched": "Bexmarilimab"
  },
  "imetelstat": {
    "is_drug": true,
    "reason": "Search results indicate imetelstat is an FDA-approved telomerase inhibitor used for the treatment of myelodysplastic syndromes (MDS).",
    "original_searched": "Imetelstat"
  },
  "asciminib": {
    "is_drug": true,
    "reason": "Search results indicate Asciminib is an FDA-approved drug used to treat chronic myeloid leukemia (CML).",
    "original_searched": "Asciminib"
  },
  "kite-363 anti-cd19/cd20 chimeric antigen receptor t-cell": {
    "is_drug": true,
    "reason": "Search results describe KITE-363 as an autologous CAR T-cell therapy targeting CD19 and CD20, used in clinical studies as a therapeutic agent for B-cell malignancies.",
    "original_searched": "KITE-363 anti-CD19/CD20 Chimeric Antigen Receptor T-Cell"
  },
  "p-gemox": {
    "is_drug": true,
    "reason": "Search results consistently describe P-GemOx as a chemotherapy regimen combining pegaspargase, gemcitabine, and oxaliplatin used for treatment of NK/T-cell lymphoma.",
    "original_searched": "P-GemOx"
  },
  "carboplatin": {
    "is_drug": true,
    "reason": "Search results indicate Carboplatin is an FDA-approved, platinum-based chemotherapy drug used to treat various cancers.",
    "original_searched": "Carboplatin"
  },
  "ifosfamide": {
    "is_drug": true,
    "reason": "Search results indicate Ifosfamide is an FDA-approved drug used in cancer treatment and is listed as an essential medicine by the WHO.",
    "original_searched": "Ifosfamide"
  },
  "acimtamig": {
    "is_drug": true,
    "reason": "Search results describe Acimtamig as a drug used in clinical trials, specifically as a bispecific NK-cell engager for the treatment of cancer, and mention its administration and safety profile.",
    "original_searched": "Acimtamig"
  },
  "allonk": {
    "is_drug": true,
    "reason": "Search results indicate AlloNK is an allogeneic cord blood-derived NK cell therapy with FDA Fast Track designation, studied as a therapeutic agent in clinical trials.",
    "original_searched": "AlloNK"
  },
  "trastuzumab": {
    "is_drug": true,
    "reason": "Search results indicate Trastuzumab is a monoclonal antibody, sold under the brand name Herceptin, approved for the treatment of breast and gastric cancer.",
    "original_searched": "Trastuzumab"
  },
  "ribociclib": {
    "is_drug": true,
    "reason": "Search results indicate Ribociclib is an FDA- and NICE-approved drug (also known as Kisqali) used for the treatment of breast cancer.",
    "original_searched": "Ribociclib"
  },
  "trastuzumab rezetecan": {
    "is_drug": true,
    "reason": "Search results indicate Trastuzumab Rezetecan is a HER2-directed antibody-drug conjugate approved by the NMPA for NSCLC treatment.",
    "original_searched": "Trastuzumab Rezetecan"
  },
  "cisplatin": {
    "is_drug": true,
    "reason": "Search results indicate Cisplatin is an FDA-approved chemotherapy drug used to treat various cancers, with official drug label information and therapeutic indications provided.",
    "original_searched": "Cisplatin"
  },
  "adebrelimab": {
    "is_drug": true,
    "reason": "Search results indicate Adebrelimab is a monoclonal antibody used in cancer treatment, specifically described as a drug and as part of approved regimens for small cell lung cancer.",
    "original_searched": "Adebrelimab"
  },
  "sacituzumab tirumotecan": {
    "is_drug": true,
    "reason": "Search results indicate sacituzumab tirumotecan is an antibody\u2013drug conjugate developed as a therapeutic agent, has been studied in clinical trials, and was granted breakthrough therapy designation by the FDA.",
    "original_searched": "Sacituzumab tirumotecan"
  },
  "pf-07248144": {
    "is_drug": true,
    "reason": "Search results indicate PF-07248144 is an investigational KAT6 inhibitor being studied as a therapeutic agent in clinical trials for cancer.",
    "original_searched": "PF-07248144"
  },
  "gedatolisib": {
    "is_drug": true,
    "reason": "Search results indicate Gedatolisib is a lead drug candidate, has an FDA new drug application, and is described as a dual PI3K/mTOR inhibitor used in clinical studies for breast cancer.",
    "original_searched": "Gedatolisib"
  },
  "trastuzumab-pkrb": {
    "is_drug": true,
    "reason": "Search results indicate Trastuzumab-pkrb (HERZUMA) is an FDA-approved intravenous drug used for the treatment of HER2-positive breast and gastric cancers.",
    "original_searched": "Trastuzumab-pkrb"
  },
  "db-1310": {
    "is_drug": true,
    "reason": "Search results indicate DB-1310 is a HER3-targeting antibody-drug conjugate (ADC) with FDA fast track status for lung cancer and is being studied as a therapeutic agent in clinical trials.",
    "original_searched": "DB-1310"
  },
  "iza-bren": {
    "is_drug": true,
    "reason": "Search results indicate Iza-bren is a bispecific antibody-drug conjugate (ADC) that has received FDA Breakthrough Therapy Designation for the treatment of non-small cell lung cancer, confirming its status as a therapeutic agent.",
    "original_searched": "iza-bren"
  },
  "bl-b01d1": {
    "is_drug": true,
    "reason": "Search results indicate BL-B01D1 is a bispecific antibody-drug conjugate targeting EGFR and HER3, with FDA clearance for clinical trials and described as being administered to patients for antitumor activity.",
    "original_searched": "BL-B01D1"
  },
  "tqb2102": {
    "is_drug": true,
    "reason": "Search results describe TQB2102 as a next-generation HER2 Antibody-Drug Conjugate (ADC) drug proposed for the treatment of breast cancer, indicating it is a therapeutic agent.",
    "original_searched": "TQB2102"
  },
  "obrixtamig": {
    "is_drug": true,
    "reason": "Search results indicate Obrixtamig is an experimental drug (also known as BI 764532) in clinical trials for cancer treatment, described as a DLL3/CD3 T-cell engager and developed by Boehringer Ingelheim.",
    "original_searched": "Obrixtamig"
  },
  "[212pb]vmt-\u03b1-net": {
    "is_drug": true,
    "reason": "Search results describe [212Pb]VMT-\u03b1-NET as a radioactive drug and radiopharmaceutical used in clinical trials for treating neuroendocrine tumors, indicating it is a therapeutic agent.",
    "original_searched": "[212Pb]VMT-\u03b1-NET"
  },
  "pemigatinib": {
    "is_drug": true,
    "reason": "Search results indicate Pemigatinib is an FDA-approved targeted therapy drug (kinase inhibitor) used for treatment of cholangiocarcinoma and other cancers.",
    "original_searched": "Pemigatinib"
  },
  "ty-9591": {
    "is_drug": true,
    "reason": "Search results indicate TY-9591 is a third-generation EGFR inhibitor developed by TYK Medicines, described as a core product and approved to enter Phase III clinical trials for oncology use.",
    "original_searched": "TY-9591"
  },
  "asandeutertinib": {
    "is_drug": true,
    "reason": "Search results indicate Asandeutertinib is an investigational small molecule drug (also known as TY-9591) being evaluated for the treatment of EGFR-mutant non-small cell lung cancer in clinical trials.",
    "original_searched": "Asandeutertinib"
  },
  "patritumab deruxtecan": {
    "is_drug": true,
    "reason": "Search results indicate Patritumab deruxtecan is a HER3-directed antibody drug conjugate with FDA Breakthrough Therapy designation and pending FDA approval for treatment of EGFR-mutated non-small cell lung cancer.",
    "original_searched": "Patritumab deruxtecan"
  },
  "anti-telomerase cd4+ t-helper vaccine": {
    "is_drug": true,
    "reason": "Search results describe anti-telomerase CD4+ T-helper vaccines as therapeutic cancer vaccines designed to stimulate immune responses against telomerase, indicating their use as therapeutic agents.",
    "original_searched": "Anti-Telomerase CD4+ T-Helper Vaccine"
  },
  "ucpvax": {
    "is_drug": true,
    "reason": "Search results indicate UCPVax is a therapeutic cancer vaccine based on telomerase-derived peptides, evaluated in clinical trials for cancer treatment.",
    "original_searched": "UCPVax"
  },
  "gene-modified autologous gamma-delta t cell": {
    "is_drug": true,
    "reason": "Search results describe gene-modified autologous gamma-delta T cells as a cell therapy administered for cancer treatment, with references to clinical studies and therapeutic use.",
    "original_searched": "Gene-Modified Autologous Gamma-Delta T Cell"
  },
  "inb-200": {
    "is_drug": true,
    "reason": "Search results indicate INB-200 is a genetically modified autologous drug resistant immunotherapy and gamma-delta T cell therapy product candidate evaluated for the treatment of solid tumors and GBM.",
    "original_searched": "INB-200"
  },
  "carv3-team-e": {
    "is_drug": true,
    "reason": "Search results indicate CARv3-TEAM-E T cells are an investigational CAR-T cell therapy being tested in clinical trials for glioblastoma treatment.",
    "original_searched": "CARv3-TEAM-E"
  },
  "mfolfox6": {
    "is_drug": true,
    "reason": "Search results indicate mFOLFOX6 is a chemotherapy regimen used for colon or rectal cancer treatment, described as a modified version of FOLFOX6.",
    "original_searched": "mFOLFOX6"
  },
  "folfox": {
    "is_drug": true,
    "reason": "Search results consistently describe FOLFOX as a combination chemotherapy regimen containing specific drugs used to treat colorectal and other gastrointestinal cancers.",
    "original_searched": "FOLFOX"
  },
  "sotorasib": {
    "is_drug": true,
    "reason": "Search results indicate Sotorasib is an FDA-approved KRAS G12C inhibitor used for the treatment of non-small cell lung cancer.",
    "original_searched": "Sotorasib"
  },
  "panitumumab": {
    "is_drug": true,
    "reason": "Search results indicate Panitumumab (Vectibix) is an FDA-approved human monoclonal antibody used for the treatment of metastatic colorectal carcinoma.",
    "original_searched": "Panitumumab"
  },
  "olomorasib": {
    "is_drug": true,
    "reason": "Search results indicate Olomorasib is an experimental anticancer drug with FDA orphan drug designation for treating KRAS G12C-mutant cancers.",
    "original_searched": "Olomorasib"
  },
  "mk-1084": {
    "is_drug": true,
    "reason": "Search results indicate MK-1084 is a KRAS G12C inhibitor being studied as a therapeutic agent in clinical trials for cancer treatment.",
    "original_searched": "MK-1084"
  },
  "osimertinib": {
    "is_drug": true,
    "reason": "Search results indicate Osimertinib is an FDA-approved antineoplastic drug used for the treatment of non-small cell lung cancer.",
    "original_searched": "Osimertinib"
  },
  "afami-cel": {
    "is_drug": true,
    "reason": "Search results indicate Afami-Cel is the first FDA-approved T-cell receptor therapy (gene therapy) for synovial sarcoma, used as a one-time treatment.",
    "original_searched": "Afami-Cel"
  },
  "dzd8586": {
    "is_drug": true,
    "reason": "Search results describe DZD8586 as a novel oral LYN/BTK dual inhibitor used in phase 1/2 clinical trials for treatment of CLL/SLL and other conditions, indicating it is an investigational therapeutic agent.",
    "original_searched": "DZD8586"
  },
  "xnw5004": {
    "is_drug": true,
    "reason": "Search results indicate XNW5004 is a proprietary, innovative EZH2 inhibitor undergoing clinical trials and has received Breakthrough Therapy Designation for treatment of peripheral T-cell lymphoma.",
    "original_searched": "XNW5004"
  },
  "shr-a1912": {
    "is_drug": true,
    "reason": "Search results indicate SHR-A1912 is a CD79b-targeted antibody-drug conjugate (ADC) developed by Hengrui Medicine, with FDA fast-track status and ongoing phase 3 clinical trials for therapeutic use.",
    "original_searched": "SHR-A1912"
  },
  "luspatercept": {
    "is_drug": true,
    "reason": "Search results indicate Luspatercept is an FDA-approved recombinant fusion protein used to treat anemia in patients with beta thalassemia and myelodysplastic syndromes.",
    "original_searched": "Luspatercept"
  },
  "epoetin alfa": {
    "is_drug": true,
    "reason": "Search results indicate Epoetin Alfa is an FDA-designated orphan drug and approved erythropoiesis-stimulating agent used for the treatment of anemia in various clinical settings.",
    "original_searched": "Epoetin Alfa"
  },
  "ipilimumab": {
    "is_drug": true,
    "reason": "Search results indicate Ipilimumab is an FDA-approved immunotherapy drug used to treat multiple cancers, including melanoma and colorectal cancer.",
    "original_searched": "Ipilimumab"
  },
  "anlotinib": {
    "is_drug": true,
    "reason": "Search results indicate Anlotinib is an approved multi-target inhibitor used as a therapeutic agent for advanced NSCLC and soft tissue sarcoma.",
    "original_searched": "Anlotinib"
  },
  "niraparib": {
    "is_drug": true,
    "reason": "Search results indicate Niraparib is an FDA-approved drug (Zejula) used as maintenance therapy for ovarian cancer.",
    "original_searched": "Niraparib"
  },
  "telisotuzumab adizutecan": {
    "is_drug": true,
    "reason": "Search results indicate Telisotuzumab adizutecan is an investigational antibody drug conjugate being developed for the treatment of solid tumors, including colorectal cancer.",
    "original_searched": "Telisotuzumab adizutecan"
  },
  "trifluridine/tipiracil": {
    "is_drug": true,
    "reason": "Search results indicate trifluridine/tipiracil is an approved chemotherapy drug combination (also known as Lonsurf) used for the treatment of metastatic colorectal cancer.",
    "original_searched": "trifluridine/tipiracil"
  },
  "amivantamab": {
    "is_drug": true,
    "reason": "Search results indicate Amivantamab is an FDA-approved medication used to treat adults with metastatic non-small cell lung cancer (NSCLC).",
    "original_searched": "Amivantamab"
  },
  "pd-1 monoclonal antibody": {
    "is_drug": true,
    "reason": "Search results indicate that PD-1 monoclonal antibody refers to a class of therapeutic agents used in cancer treatment, with clinical studies and standard therapy protocols described using this term.",
    "original_searched": "PD-1 Monoclonal Antibody"
  },
  "docetaxel": {
    "is_drug": true,
    "reason": "Search results indicate Docetaxel is a chemotherapy drug used in the treatment of various cancers, including breast, lung, prostate, and gastric cancer.",
    "original_searched": "Docetaxel"
  },
  "vepdegestrant": {
    "is_drug": true,
    "reason": "Search results indicate vepdegestrant is a drug with an FDA-accepted new drug application for the treatment of ER+/HER2\u2013, ESR1-mutated advanced breast cancer.",
    "original_searched": "Vepdegestrant"
  },
  "fulvestrant": {
    "is_drug": true,
    "reason": "Search results indicate Fulvestrant is a systemic therapy and chemotherapy drug used to treat advanced breast cancer, with prescribing and administration information provided.",
    "original_searched": "Fulvestrant"
  },
  "ramucirumab": {
    "is_drug": true,
    "reason": "Search results indicate Ramucirumab is an FDA-approved targeted therapy drug (angiogenesis inhibitor) used in cancer treatment.",
    "original_searched": "Ramucirumab"
  },
  "paclitaxel": {
    "is_drug": true,
    "reason": "Search results indicate Paclitaxel is a chemotherapy drug used in various cancer treatment regimens, with details on dosing, administration, and therapeutic indications.",
    "original_searched": "Paclitaxel"
  },
  "hlx22": {
    "is_drug": true,
    "reason": "Search results indicate HLX22 is an anti-HER2 monoclonal antibody that has received FDA orphan drug designation for the treatment of gastric cancer.",
    "original_searched": "HLX22"
  },
  "axitinib": {
    "is_drug": true,
    "reason": "Search results indicate Axitinib is an FDA- and EMA-approved drug used to treat advanced renal cell carcinoma.",
    "original_searched": "Axitinib"
  },
  "tagitanlimab": {
    "is_drug": true,
    "reason": "Search results indicate Tagitanlimab is a humanized monoclonal antibody (anti-PD-L1) that has received marketing authorization from the NMPA in China for the treatment of recurrent or metastatic nasopharyngeal cancer.",
    "original_searched": "Tagitanlimab"
  },
  "cemiplimab": {
    "is_drug": true,
    "reason": "Search results indicate cemiplimab is an FDA-approved monoclonal antibody (immune checkpoint inhibitor) used for the treatment of advanced cutaneous squamous cell carcinoma.",
    "original_searched": "cemiplimab"
  },
  "regn7075": {
    "is_drug": true,
    "reason": "Search results indicate REGN7075 is an investigational drug being studied for the treatment of advanced cancers and is described as a bispecific therapeutic agent.",
    "original_searched": "REGN7075"
  },
  "fianlimab": {
    "is_drug": true,
    "reason": "Search results describe fianlimab as an experimental drug (REGN3767) and a LAG-3 inhibitor being tested in clinical trials for cancer treatment.",
    "original_searched": "Fianlimab"
  },
  "bms-986489": {
    "is_drug": true,
    "reason": "Search results indicate BMS-986489 is an investigational drug regimen consisting of a fixed-dose combination of atigotatug (anti-fucosyl-GM1) and nivolumab, being tested for therapeutic use in small cell lung cancer.",
    "original_searched": "BMS-986489"
  },
  "atigotatug": {
    "is_drug": true,
    "reason": "Search results indicate Atigotatug is a first-in-class, fully human IgG1 antibody developed for the treatment of SCLC and is described as an experimental drug in clinical trials.",
    "original_searched": "Atigotatug"
  },
  "atezolizumab": {
    "is_drug": true,
    "reason": "Search results indicate Atezolizumab is an FDA-approved immunotherapy drug (PD-L1 inhibitor) used for the treatment of various cancers.",
    "original_searched": "Atezolizumab"
  },
  "tamoxifen": {
    "is_drug": true,
    "reason": "Search results indicate Tamoxifen is an FDA-approved antiestrogen drug used for the treatment and prevention of breast cancer.",
    "original_searched": "Tamoxifen"
  },
  "acolbifene": {
    "is_drug": true,
    "reason": "Search results indicate Acolbifene is an estrogen receptor modulator (SERM) investigated as a prevention drug for breast cancer, with clinical trials and drug dictionary entries describing its therapeutic use.",
    "original_searched": "Acolbifene"
  },
  "hlx07": {
    "is_drug": true,
    "reason": "Search results indicate HLX07 is a novel, recombinant, humanized anti-EGFR monoclonal antibody with demonstrated anti-cancer effects and is being studied as a therapeutic agent.",
    "original_searched": "HLX07"
  },
  "ripretinib": {
    "is_drug": true,
    "reason": "Search results indicate Ripretinib is an FDA-approved oral therapy for advanced gastrointestinal stromal tumors and is described as a drug used in cancer treatment.",
    "original_searched": "Ripretinib"
  },
  "sunitinib": {
    "is_drug": true,
    "reason": "Search results indicate Sunitinib is an FDA-approved drug used to treat various cancers, including metastatic renal cell cancer and gastrointestinal stromal tumor.",
    "original_searched": "Sunitinib"
  },
  "tremelimumab": {
    "is_drug": true,
    "reason": "Search results indicate Tremelimumab is an FDA- and EMA-approved drug used in combination therapy for cancer treatment.",
    "original_searched": "Tremelimumab"
  },
  "cyclophosphosphamide": {
    "is_drug": true,
    "reason": "Search results consistently describe cyclophosphamide as an FDA-approved drug used to treat various cancers and autoimmune diseases.",
    "original_searched": "Cyclophosphosphamide"
  },
  "lazertinib": {
    "is_drug": true,
    "reason": "Search results indicate Lazertinib is an FDA-approved tyrosine kinase inhibitor used to treat non-small cell lung cancer with EGFR mutations.",
    "original_searched": "Lazertinib"
  },
  "donafenib": {
    "is_drug": true,
    "reason": "Search results indicate Donafenib is a pharmaceutical drug approved in China for the treatment of cancer and described as a multikinase inhibitor used in hepatocellular carcinoma.",
    "original_searched": "Donafenib"
  },
  "protein-bound paclitaxel": {
    "is_drug": true,
    "reason": "Search results indicate that protein-bound paclitaxel is an FDA-approved drug used to treat advanced breast, lung, and pancreatic cancers.",
    "original_searched": "Protein-bound paclitaxel"
  },
  "solvent-based paclitaxel": {
    "is_drug": true,
    "reason": "Search results indicate solvent-based paclitaxel is a standard chemotherapy regimen used in the treatment of advanced cancers, and is compared to other formulations like nab-paclitaxel in clinical guidelines and trials.",
    "original_searched": "solvent-based paclitaxel"
  },
  "flot": {
    "is_drug": true,
    "reason": "Search results indicate FLOT is a combination chemotherapy regimen consisting of fluorouracil, leucovorin, oxaliplatin, and docetaxel, used to treat stomach and esophageal cancer.",
    "original_searched": "FLOT"
  },
  "177lut psma": {
    "is_drug": true,
    "reason": "Search results indicate that 177Lu-PSMA (Lutetium-177 PSMA) is an FDA-approved radioligand therapy used to treat metastatic castration-resistant prostate cancer.",
    "original_searched": "177Lut PSMA"
  },
  "cabazitaxel": {
    "is_drug": true,
    "reason": "Search results indicate Cabazitaxel is an FDA and EMA-approved antineoplastic agent used to treat metastatic castration-resistant prostate cancer.",
    "original_searched": "Cabazitaxel"
  },
  "177lu-vipivotide tetraxetan": {
    "is_drug": true,
    "reason": "Search results indicate that 177Lu-vipivotide tetraxetan (Pluvicto) is an FDA-approved radiopharmaceutical therapeutic agent used for the treatment of PSMA-positive metastatic castration-resistant prostate cancer.",
    "original_searched": "177Lu-vipivotide tetraxetan"
  },
  "bcg": {
    "is_drug": true,
    "reason": "Search results indicate BCG (Bacillus Calmette-Gu\u00e9rin) is used as a vaccine for tuberculosis and as an intravesical immunotherapy drug for bladder cancer treatment.",
    "original_searched": "BCG"
  },
  "sacituzumab govitecan": {
    "is_drug": true,
    "reason": "Search results indicate Sacituzumab govitecan is an FDA- and EMA-approved drug used for the treatment of metastatic breast and urothelial cancers.",
    "original_searched": "Sacituzumab govitecan"
  },
  "pertuzumab": {
    "is_drug": true,
    "reason": "Search results indicate Pertuzumab is an FDA-approved monoclonal antibody (sold as Perjeta) used in combination therapy for HER2-positive breast cancer.",
    "original_searched": "Pertuzumab"
  },
  "taxane": {
    "is_drug": true,
    "reason": "Search results indicate that taxane refers to a class of chemotherapy drugs, including paclitaxel and docetaxel, which are approved and commonly prescribed anticancer agents.",
    "original_searched": "Taxane"
  },
  "trastuzumab deruxtecan": {
    "is_drug": true,
    "reason": "Search results indicate trastuzumab deruxtecan is an FDA-approved antibody\u2013drug conjugate used for the treatment of HER2-positive and HER2-low breast cancer.",
    "original_searched": "Trastuzumab deruxtecan"
  },
  "ag": {
    "is_drug": false,
    "reason": "Search results indicate 'AG' refers to 'authorized generic' drugs as a category, not a specific drug or therapeutic agent.",
    "original_searched": "AG"
  },
  "benmelstobart": {
    "is_drug": true,
    "reason": "Search results describe Benmelstobart as a PD-L1 inhibitor and T lymphocyte stimulant drug developed by a biotech company, and it is used in combination regimens in clinical trials for cancer treatment.",
    "original_searched": "Benmelstobart"
  },
  "177lu-dotatate": {
    "is_drug": true,
    "reason": "Search results indicate 177Lu-DOTATATE (Lutathera) is an FDA-approved radiolabeled somatostatin analog used for the treatment of gastroenteropancreatic neuroendocrine tumors.",
    "original_searched": "177Lu-DOTATATE"
  },
  "sunitinib malate": {
    "is_drug": true,
    "reason": "Search results indicate Sunitinib Malate is an FDA-approved oral anti-cancer medication used to treat several types of cancer.",
    "original_searched": "Sunitinib Malate"
  },
  "lutetium (lu-177) dotatate": {
    "is_drug": true,
    "reason": "Search results indicate Lutetium (Lu-177) Dotatate is an FDA-approved radiopharmaceutical (Lutathera) used for the treatment of somatostatin receptor\u2013positive gastroenteropancreatic neuroendocrine tumors.",
    "original_searched": "Lutetium (Lu-177) Dotatate"
  },
  "1,3-bis-(2-chloroethyl)-1-nitrosourea": {
    "is_drug": true,
    "reason": "Search results indicate that 1,3-bis-(2-chloroethyl)-1-nitrosourea (also known as BCNU or carmustine) is used as a chemotherapeutic agent in cancer treatment and has been studied in clinical trials.",
    "original_searched": "1,3-bis-(2-chloroethyl)-1-nitrosourea"
  },
  "[18f]fluoroestradiol": {
    "is_drug": false,
    "reason": "Search results indicate [18F]fluoroestradiol is an FDA-approved radiolabeled imaging agent used for PET scans to detect estrogen receptor status, not as a therapeutic drug or regimen.",
    "original_searched": "[18F]fluoroestradiol"
  },
  "psma pet": {
    "is_drug": false,
    "reason": "Search results indicate PSMA PET refers to a type of imaging scan (PET scan using PSMA-targeted tracers) for prostate cancer diagnosis and management, not a drug or therapeutic agent.",
    "original_searched": "PSMA PET"
  },
  "[177lu] lu psma": {
    "is_drug": true,
    "reason": "Search results indicate that [177Lu] Lu PSMA (also referred to as 177Lu-PSMA-617 or lutetium Lu 177 vipivotide tetraxetan) is an FDA-approved radioligand therapy for metastatic castration-resistant prostate cancer.",
    "original_searched": "[177Lu] Lu PSMA"
  },
  "[177lu]lu-psma-617": {
    "is_drug": true,
    "reason": "Search results indicate [177Lu]Lu-PSMA-617 (Pluvicto) is an FDA-approved radioligand therapy for metastatic castration-resistant prostate cancer.",
    "original_searched": "[177Lu]Lu-PSMA-617"
  },
  "177lu girentuximab": {
    "is_drug": true,
    "reason": "Search results describe 177Lu girentuximab as a radioimmunoconjugate used in clinical trials for the treatment of advanced clear cell renal cell carcinoma, indicating it is a therapeutic agent.",
    "original_searched": "177Lu girentuximab"
  },
  "177lu-girentuximab": {
    "is_drug": true,
    "reason": "Search results describe 177Lu-girentuximab as a radioimmunoconjugate consisting of girentuximab labeled with Lutetium-177, used therapeutically in clinical trials for renal cell carcinoma.",
    "original_searched": "177Lu-girentuximab"
  },
  "girentuximab": {
    "is_drug": true,
    "reason": "Search results indicate Girentuximab is an antibody drug with FDA orphan drug designation and fast track status for renal cancer, used as a therapeutic agent.",
    "original_searched": "Girentuximab"
  },
  "177 lutetium-dotatate": {
    "is_drug": true,
    "reason": "Search results indicate that lutetium Lu 177-dotatate is an FDA-approved drug used to treat gastroenteropancreatic neuroendocrine tumors, with specific mention of its therapeutic use and administration protocols.",
    "original_searched": "177 lutetium-dotatate"
  },
  "[212pb]vmt01": {
    "is_drug": true,
    "reason": "Search results indicate [212Pb]VMT01 is an alpha-particle emitting therapeutic agent in clinical trials for melanoma, with FDA fast track designation for treatment purposes.",
    "original_searched": "[212Pb]VMT01"
  },
  "[177lu]lu-psma": {
    "is_drug": true,
    "reason": "Search results indicate [177Lu]Lu-PSMA refers to FDA-approved radioligand therapies such as 177Lu-PSMA-617 (Pluvicto) used for the treatment of metastatic castration-resistant prostate cancer.",
    "original_searched": "[177Lu]Lu-PSMA"
  },
  "[89zr]zr-dfo-sc16.56 anti-dll3 antibody": {
    "is_drug": false,
    "reason": "Search results indicate [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody is used as a non-invasive immunoPET imaging probe for detection of DLL3-expressing malignancies, not as a therapeutic agent.",
    "original_searched": "[89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody"
  },
  "\u00b9\u00b3\u00b9i": {
    "is_drug": true,
    "reason": "Search results indicate that \u00b9\u00b3\u00b9I (Iodine-131) is administered as a treatment for Graves disease and abnormal thyroid conditions, confirming its use as a therapeutic agent.",
    "original_searched": "\u00b9\u00b3\u00b9I"
  },
  "[18f]16\u03b1-fluoro-17\u03b2-fluoroestradiol": {
    "is_drug": false,
    "reason": "Search results indicate [18F]16\u03b1-fluoro-17\u03b2-fluoroestradiol (18F-FES) is an FDA-approved radiopharmaceutical used as a diagnostic imaging agent for estrogen receptor detection, not as a therapeutic drug or regimen.",
    "original_searched": "[18F]16\u03b1-fluoro-17\u03b2-fluoroestradiol"
  },
  "[68 ga]ga-psma-11": {
    "is_drug": true,
    "reason": "Search results indicate that [68 Ga]Ga-PSMA-11 is an FDA-approved drug used for PET imaging in the management of prostate cancer.",
    "original_searched": "[68 Ga]Ga-PSMA-11"
  },
  "177lu-catelase": {
    "is_drug": true,
    "reason": "Search results mention 'Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy,' indicating it is used as a therapeutic agent in cancer treatment.",
    "original_searched": "177Lu-catelase"
  },
  "177lu-jh020002": {
    "is_drug": true,
    "reason": "Search results indicate 177Lu-JH020002 is described as a novel radioligand therapy delivering beta-particle radiation to tumor cells, suggesting it is a therapeutic agent used in treatment.",
    "original_searched": "177Lu-JH020002"
  },
  "allogeneic double-negative t cell": {
    "is_drug": true,
    "reason": "Search results indicate that allogeneic double-negative T cells are being developed and used as a cell therapy with immunomodulating and anti-leukemic activities, including in early clinical trials for acute myeloid leukemia.",
    "original_searched": "Allogeneic Double-Negative T Cell"
  },
  "ipsc-derived mesenchymal stem cells": {
    "is_drug": true,
    "reason": "Search results indicate that iPSC-derived mesenchymal stem cells (iPSC-MSCs) are used for therapeutic purposes and cell therapy development, suggesting their use as a therapeutic agent.",
    "original_searched": "iPSC-derived mesenchymal stem cells"
  },
  "prag": {
    "is_drug": true,
    "reason": "Search results describe PRaG as a regimen combining hypofractionated radiotherapy, PD-1 inhibitor, and granulocyte-macrophage colony-stimulating factor, used therapeutically in clinical studies for solid tumors.",
    "original_searched": "PRaG"
  },
  "camrelizumab": {
    "is_drug": true,
    "reason": "Search results indicate Camrelizumab is a monoclonal antibody PD-1 inhibitor used as a therapeutic agent in cancer treatment.",
    "original_searched": "Camrelizumab"
  },
  "tislelizumab": {
    "is_drug": true,
    "reason": "Search results indicate Tislelizumab is an FDA- and EMA-approved anti-PD-1 antibody used as monotherapy and in combination for the treatment of multiple cancers.",
    "original_searched": "Tislelizumab"
  },
  "gm-csf": {
    "is_drug": true,
    "reason": "Search results indicate GM-CSF is administered as a medicine (e.g., Sargramostim) via injection or IV and is used therapeutically in various conditions.",
    "original_searched": "GM-CSF"
  },
  "il-2": {
    "is_drug": true,
    "reason": "Search results indicate IL-2 (Interleukin-2) is used as a drug (Proleukin\u00ae, Aldesleukin) in treatment regimens for metastatic cancers and HIV, with dosing protocols and side effect profiles described.",
    "original_searched": "IL-2"
  },
  "fshr-targeted autologous t-cell": {
    "is_drug": true,
    "reason": "Search results indicate FSHR-Targeted Autologous T-Cell is an engineered cell therapy (CAR T-cell) used as a therapeutic agent targeting FSHR in cancer treatment, with FDA IND approval and clinical trials mentioned.",
    "original_searched": "FSHR-Targeted Autologous T-Cell"
  },
  "bc3195": {
    "is_drug": true,
    "reason": "Search results indicate BC3195 is a novel antibody-drug conjugate (ADC) undergoing clinical trials for use in patients with advanced solid tumors, with studies describing its safety, pharmacokinetics, and intravenous administration.",
    "original_searched": "BC3195"
  },
  "rc48-adc": {
    "is_drug": true,
    "reason": "Search results indicate RC48-ADC is a novel HER2-targeting antibody-drug conjugate (ADC) with therapeutic use in cancer patients, and is also referred to as Disitamab vedotin.",
    "original_searched": "RC48-ADC"
  },
  "belinostat": {
    "is_drug": true,
    "reason": "Search results indicate Belinostat is an FDA-approved drug used for the treatment of relapsed or refractory peripheral T-cell lymphoma.",
    "original_searched": "Belinostat"
  },
  "talazoparib": {
    "is_drug": true,
    "reason": "Search results indicate Talazoparib is an FDA-approved PARP inhibitor used as a prescription medication for the treatment of BRCA-mutated breast and prostate cancer.",
    "original_searched": "Talazoparib"
  },
  "ace-86225106": {
    "is_drug": true,
    "reason": "Search results indicate ACE-86225106 is administered orally as a treatment regimen for patients with advanced solid tumors, suggesting it is an investigational therapeutic agent.",
    "original_searched": "ACE-86225106"
  },
  "chimeric antigen receptor t cell": {
    "is_drug": true,
    "reason": "Search results consistently describe Chimeric Antigen Receptor T Cell (CAR-T) as a therapeutic approach and product used in the treatment of hematologic malignancies and other diseases.",
    "original_searched": "Chimeric Antigen Receptor T Cell"
  },
  "trilaciclib": {
    "is_drug": true,
    "reason": "Search results indicate Trilaciclib (Cosela) is an FDA-approved drug used to decrease chemotherapy-induced myelosuppression in adult patients.",
    "original_searched": "Trilaciclib"
  },
  "sorafenib": {
    "is_drug": true,
    "reason": "Search results indicate Sorafenib is an FDA-approved targeted therapy drug used for the treatment of advanced cancers such as hepatocellular carcinoma and renal cell carcinoma.",
    "original_searched": "Sorafenib"
  },
  "elritercept": {
    "is_drug": true,
    "reason": "Search results indicate Elritercept is an investigational drug with FDA Fast Track designation for treating anemia in MDS, and is described as a modified activin receptor IIA ligand trap developed for therapeutic use.",
    "original_searched": "Elritercept"
  },
  "ice regimen": {
    "is_drug": true,
    "reason": "Search results indicate that ICE Regimen is a chemotherapy regimen consisting of ifosfamide, carboplatin, and etoposide, used for treating relapsed or refractory lymphoma.",
    "original_searched": "Ice Regimen"
  },
  "zuberitamab": {
    "is_drug": true,
    "reason": "Search results indicate Zuberitamab is an approved anti-CD20 monoclonal antibody used for the treatment of diffuse large B-cell lymphoma and chronic ITP, and is included in the National Medical Insurance Drug List.",
    "original_searched": "Zuberitamab"
  }
}